Lord's Mark Industries Launches IVD Facility
Analysis based on 6 articles · First reported Jun 24, 2026 · Last updated Jun 25, 2026
The launch of Lord s Mark Industries' new IVD manufacturing facility and its ambitious expansion plans are expected to positively impact the medical devices and biotechnology industries in India. This move could lead to increased domestic production, reduced reliance on imports, and position India as a significant player in global medical technology, potentially attracting further investment and fostering innovation in the sector.
Lord s Mark Industries has launched a new 14,000 sq. ft. In Vitro Diagnostics (IVD) manufacturing facility in Vasai (East), India — Maharashtra, two months ahead of its August 2026 schedule. This expands the company's total operational manufacturing space to 34,000 sq. ft., enhancing production of ELISA and rapid test kits. The facility's R&D division is dedicated to the memory of Shri Ratan Tata, focusing on indigenous molecular biology research. Lord s Mark Industries also announced plans for a third facility in Vasai, India — Maharashtra, dedicated to Dr. A.P.J. Abdul Kalam, for early cancer detection, expected by January 2029. The company aims to build one of the world's largest medical device manufacturing plants in India, focusing on AI-enabled and imaging-based diagnostic devices, to position India as a global medical-technology manufacturing hub.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard